Jason K Hou1, Hoda M Malaty, Selvi Thirumurthi. 1. Houston VA HSR&D Center of Excellence; Michael E. DeBakey Veterans Affairs Hospital, 1709 Dryden Road, Suite 8.40, MS: BCM 620, Houston, TX, 77030, USA, jkhou@bcm.tmc.edu.
Abstract
BACKGROUND/AIMS: Radiographic imaging studies are important in the management of patients with inflammatory bowel disease (IBD), but are associated with radiation exposure. IBD patients in a safety-net health-care system may be at risk of high exposure to radiation. Our purpose was to identify associations of high-dose radiation exposure among an ethnically diverse cohort of IBD patients in a safety-net health-care system. METHODS: A study was performed on patients with IBD receiving care from the Harris County Hospital District. Radiation exposure was calculated using total number of imaging studies performed between from 2000 and 2010 and estimates of radiation dose per study. Associations of high-dose radiation exposure, defined as a cumulative effective dose (CED) >50 mSv, were identified by using univariate and multivariate logistic regression. RESULTS: The study cohort of 278 patients with IBD was ethnically diverse, with 30 % Caucasian, 44 % African-American, and 26 % Hispanic. The median CED was 10.40 mSv (SD 20.02). Annualized radiation doses were 3.45 mSv/year among patients with Crohn's disease (CD) and 1.27 mSv/year among patients with ulcerative colitis, p < 0.02. Approximately 13 % of IBD patients received a CED >50 mSv. There were no differences in radiation exposure based on age, gender, or race/ethnicity. CONCLUSIONS: A small proportion of IBD patients in a safety-net health-care system received high doses of diagnostic radiation exposure. Use of diagnostic imaging studies that limit radiation exposure should be encouraged.
BACKGROUND/AIMS: Radiographic imaging studies are important in the management of patients with inflammatory bowel disease (IBD), but are associated with radiation exposure. IBDpatients in a safety-net health-care system may be at risk of high exposure to radiation. Our purpose was to identify associations of high-dose radiation exposure among an ethnically diverse cohort of IBDpatients in a safety-net health-care system. METHODS: A study was performed on patients with IBD receiving care from the Harris County Hospital District. Radiation exposure was calculated using total number of imaging studies performed between from 2000 and 2010 and estimates of radiation dose per study. Associations of high-dose radiation exposure, defined as a cumulative effective dose (CED) >50 mSv, were identified by using univariate and multivariate logistic regression. RESULTS: The study cohort of 278 patients with IBD was ethnically diverse, with 30 % Caucasian, 44 % African-American, and 26 % Hispanic. The median CED was 10.40 mSv (SD 20.02). Annualized radiation doses were 3.45 mSv/year among patients with Crohn's disease (CD) and 1.27 mSv/year among patients with ulcerative colitis, p < 0.02. Approximately 13 % of IBDpatients received a CED >50 mSv. There were no differences in radiation exposure based on age, gender, or race/ethnicity. CONCLUSIONS: A small proportion of IBDpatients in a safety-net health-care system received high doses of diagnostic radiation exposure. Use of diagnostic imaging studies that limit radiation exposure should be encouraged.
Authors: C R Muirhead; A A Goodill; R G Haylock; J Vokes; M P Little; D A Jackson; J A O'Hagan; J M Thomas; G M Kendall; T J Silk; D Bingham; G L Berridge Journal: J Radiol Prot Date: 1999-03 Impact factor: 1.394
Authors: E Cardis; M Vrijheid; M Blettner; E Gilbert; M Hakama; C Hill; G Howe; J Kaldor; C R Muirhead; M Schubauer-Berigan; T Yoshimura; F Bermann; G Cowper; J Fix; C Hacker; B Heinmiller; M Marshall; I Thierry-Chef; D Utterback; Y-O Ahn; E Amoros; P Ashmore; A Auvinen; J-M Bae; J Bernar Solano; A Biau; E Combalot; P Deboodt; A Diez Sacristan; M Eklof; H Engels; G Engholm; G Gulis; R Habib; K Holan; H Hyvonen; A Kerekes; J Kurtinaitis; H Malker; M Martuzzi; A Mastauskas; A Monnet; M Moser; M S Pearce; D B Richardson; F Rodriguez-Artalejo; A Rogel; H Tardy; M Telle-Lamberton; I Turai; M Usel; K Veress Journal: BMJ Date: 2005-06-29
Authors: Joanna M Peloquin; Darrell S Pardi; William J Sandborn; Joel G Fletcher; Cynthia H McCollough; Beth A Schueler; James A Kofler; Felicity T B Enders; Sara J Achenbach; Edward V Loftus Journal: Am J Gastroenterol Date: 2008-06-28 Impact factor: 10.864
Authors: Lena Palmer; Hans Herfarth; Carol Q Porter; Lynn A Fordham; Robert S Sandler; Michael D Kappelman Journal: Am J Gastroenterol Date: 2009-08-18 Impact factor: 10.864
Authors: Z Levi; E Fraser; R Krongrad; R Hazazi; O benjaminov; J meyerovitch; O B Tal; A Choen; Y Niv; G Fraser Journal: Aliment Pharmacol Ther Date: 2009-12-01 Impact factor: 8.171
Authors: David J Brenner; Richard Doll; Dudley T Goodhead; Eric J Hall; Charles E Land; John B Little; Jay H Lubin; Dale L Preston; R Julian Preston; Jerome S Puskin; Elaine Ron; Rainer K Sachs; Jonathan M Samet; Richard B Setlow; Marco Zaider Journal: Proc Natl Acad Sci U S A Date: 2003-11-10 Impact factor: 11.205
Authors: Jeevinesh Naidu; Zhiqin Wong; Shanthi Palaniappan; Chai Soon Ngiu; Nur Yazmin Yaacob; Hamzaini Abdul Hamid; Marjanu Hikmah Elias; Norfilza Mohamad Mokhtar; Raja Affendi Raja Ali Journal: Asian Pac J Cancer Prev Date: 2017-04-01